Ken Griffin Personalis, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Personalis, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 27,500 shares of PSNL stock, worth $137,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,500

Previous 800 3337.5%

Holding current value

$137,500

Previous $1,000 3100.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.17 - $1.65 $178,186 - $251,288	-152,296 Reduced 30.01%	355,241 $415,000
Q1 2024 May 15, 2024	BUY	$1.15 - $2.19 $86,700 - $165,108	75,392 Added 17.45%	507,537 $756,000
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.35 $288,150 - $728,121	309,839 Added 253.33%	432,145 $907,000
Q3 2023 Nov 14, 2023	SELL	$1.19 - $2.36 $50,827 - $100,800	-42,712 Reduced 25.88%	122,306 $147,000
Q2 2023 Aug 14, 2023	SELL	$1.8 - $3.19 $96,863 - $171,663	-53,813 Reduced 24.59%	165,018 $310,000
Q1 2023 May 15, 2023	SELL	$2.01 - $4.17 $34,831 - $72,261	-17,329 Reduced 7.34%	218,831 $603,000
Q4 2022 Feb 14, 2023	BUY	$1.78 - $3.64 $49,742 - $101,719	27,945 Added 13.42%	236,160 $467,000
Q3 2022 Nov 14, 2022	SELL	$2.89 - $5.32 $734,854 - $1.35 Million	-254,275 Reduced 54.98%	208,215 $618,000
Q2 2022 Aug 15, 2022	BUY	$3.27 - $8.76 $943,097 - $2.53 Million	288,409 Added 165.68%	462,490 $1.6 Million
Q1 2022 May 16, 2022	BUY	$7.56 - $14.3 $147,911 - $279,779	19,565 Added 12.66%	174,081 $1.43 Million
Q4 2021 Feb 14, 2022	SELL	$12.24 - $21.25 $962,455 - $1.67 Million	-78,632 Reduced 33.73%	154,516 $2.2 Million
Q3 2021 Nov 15, 2021	SELL	$16.69 - $26.05 $334,484 - $522,068	-20,041 Reduced 7.92%	233,148 $4.49 Million
Q2 2021 Aug 16, 2021	SELL	$18.15 - $27.75 $1.69 Million - $2.59 Million	-93,286 Reduced 26.92%	253,189 $6.41 Million
Q1 2021 May 17, 2021	BUY	$20.71 - $51.02 $4.31 Million - $10.6 Million	208,296 Added 150.74%	346,475 $8.53 Million
Q4 2020 Feb 16, 2021	SELL	$21.84 - $44.0 $2.4 Million - $4.84 Million	-109,893 Reduced 44.3%	138,179 $5.06 Million
Q3 2020 Nov 16, 2020	BUY	$13.63 - $24.12 $2.47 Million - $4.38 Million	181,431 Added 272.25%	248,072 $5.38 Million
Q2 2020 Aug 14, 2020	SELL	$7.65 - $14.11 $211,208 - $389,562	-27,609 Reduced 29.29%	66,641 $865,000
Q1 2020 May 15, 2020	SELL	$4.75 - $12.41 $36,940 - $96,512	-7,777 Reduced 7.62%	94,250 $760,000
Q4 2019 Feb 14, 2020	SELL	$8.73 - $12.95 $116,205 - $172,377	-13,311 Reduced 11.54%	102,027 $1.11 Million
Q3 2019 Nov 14, 2019	SELL	$14.16 - $25.34 $66,042 - $118,185	-4,664 Reduced 3.89%	115,338 $1.69 Million
Q2 2019 Aug 14, 2019	BUY	$27.0 - $30.25 $3.24 Million - $3.63 Million	120,002 New	120,002 $3.26 Million

Others Institutions Holding PSNL

# of Institutions

Shares Held

23.1M

Call Options Held

27.5K

Put Options Held

View Full List

About Personalis, Inc.

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $230M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

More about PSNL

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account